Skip to main content
Clinical Trials/ISRCTN93939200
ISRCTN93939200
Completed
未知

Clinical assessment of a new catheter surface coating with antimicrobial properties: efficacy and effect of intensive catheter and exit site care education

Gambro Dialysatoren GmbH (Germany)0 sites180 target enrollmentSeptember 19, 2007

Overview

Phase
未知
Intervention
Not specified
Conditions
Renal disease
Sponsor
Gambro Dialysatoren GmbH (Germany)
Enrollment
180
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 19, 2007
End Date
January 31, 2009
Last Updated
7 years ago
Study Type
Interventional

Investigators

Sponsor
Gambro Dialysatoren GmbH (Germany)

Eligibility Criteria

Inclusion Criteria

  • 1\. Need for extracorporeal renal replacement therapy (acute and chronic renal failure)
  • 2\. Age over 18 years
  • 3\. Written informed consent
  • 4\. Needed catheter length 15 cm or 20 cm

Exclusion Criteria

  • 1\. Known infectivity with Hepatitis B Virus (HBV)/Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV)
  • 2\. Any infection associated with one or more positive blood cultures within 10 days prior to catheter implantation
  • 3\. Bacteremia with a former catheter within 10 days prior to catheter implantation
  • 4\. Known pregnancy
  • 5\. Lactation
  • 6\. Participation in another clinical study during the preceding 30 days

Outcomes

Primary Outcomes

Not specified

Similar Trials